Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma

Clinical trial NCT06410248 · RECRUITING

Trial details

NCT number: NCT06410248
Sponsor: Northwestern University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma, IDH-Wildtype Recurrent WHO Grade 2 Glioma Recurrent WHO Grade 3 Glioma Recurrent WHO Grade 4 Glioma

Start date: 2024-07-23
Primary completion: 2029-05-12
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.